More on NWBO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/21/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NWBO Cash Flow Statement

Click line-items for a historical chart and %
Net loss -49.51M
Depreciation and amortization
Amortization of deferred financing costs 639K
Amortization debt discount
Derivative valuation (gain) loss
Accrued interest converted to preferred stock
Accreted interest on convertible promissory note
Stock-based compensation costs 98K
Stock and warrants issued for services and other expenses
Loan conversion inducement 1.46M
Valuation of reclassified equity contracts
Asset impairment loss and loss (gain) on sale of properties
Loss on facility sublease
Prepaid expenses and other current assets
Accounts payable and accrued expenses 1.7M
Related party accounts payable and accrued expenses 6.39M
Accrued loss on sublease
Deferred rent
Net Cash used in Operating Activities
Purchase of property and equipment, net
Proceeds from sale of property and equipment
Proceeds from sale of intellectual property
Proceeds from sale of marketable securities
Refund of security deposit
Transfer of restricted cash
Net Cash used in Investing Activities
Proceeds from issuance of note payable
Proceeds from issuance of convertible notes payable to related parties
Proceeds from issuance of note payable to related parties
Repayment of note payable to related party
Proceeds from issuance of convertible promissory note and warrants, net of issuance costs
Repayment of convertible promissory note
Borrowing under line of credit, Northwest Hospital
Repayment of line of credit, Northwest Hospital
Payment on capital lease obligations
Payments on note payable
Proceeds from issuance preferred stock, net
Proceeds from exercise of stock options and warrants
Proceeds from issuance common stock, net
Proceeds for sale of stock warrant
Payment of preferred stock dividends
Series A preferred stock redemption fee
Deferred financing costs
Net Cash provided by Financing Activities
Effect of exchange rates on cash 3.94M
Net increase in cash -21.01M
Cash at beginning of period 21.81M
Cash at end of period 802K
Supplemental disclosure of cash flow information - Cash paid during the period for interest -550K
Supplemental schedule of non-cash financing activities:
Equipment acquired through capital leases
Issuance of common stock in connection with elimination of Series A and Series A-1 preferred stock preferences
Issuance of common stock in connection conversion of notes payable and accrued interest notes
Warrants issued on Series A and Series A-1 preferred stock dividends
Common stock warrant liability
Accretion of mandatorily redeemable Series A preferred stock redemption obligation
Debt discount on promissory notes
Issuance of Series C preferred stock warrants in connection with lease agreement
Issuance of common stock to settle accounts payable
Liability for and issuance of common stock and warrants to Medarex
Issuance of common stock to landlord
Deferred compensation on issuance of stock options and restricted stock grants
Cancellation of options and restricted stock
Financing of prepaid insurance through note payable
Stock subscription receivable
Supplemental schedule of non-cash financing activities:
Modification of preferred stock warrants
Supplemental schedule of non-cash financing activities:
Modification of preferred stock warrants
Conversion of convertible promissory notes and accrued interest to stock
Supplemental schedule of non-cash financing activities:
Conversion of convertible promissory notes and accrued interest to stock
Supplemental schedule of non-cash financing activities:
Conversion of convertible promissory notes and accrued interest to stock

Entities mentioned with NWBO

View All Entities